[Bone marrow grafts after total irradiation of leukemic mice followed by administration of an antimitotic agent to reduce the incidence of a secondary syndrome and to enhance the antileukemic effect].
D000818:Animals; D050256:Antimitotic Agents; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001853:Bone Marrow; D016026:Bone Marrow Transplantation; D005493:Folic Acid Antagonists / Q000494:pharmacology*; D015994:Incidence; D007942:Leukemia, Experimental; D051379:Mice; D011830:Radiation Effects; D019737:Transplants
D050256:Antimitotic Agents; D000970:Antineoplastic Agents; D005493:Folic Acid Antagonists
ANTINEOPLASTIC AGENTS/pharmacology; BONE MARROW/transplantation; FOLIC ACID ANTAGONISTS/pharmacology; LEUKEMIA/experimental; RADIATION EFFECTS/experimental